Innovating Shorter, All- Oral, Precised Treatment Regimen for Rifampicin Resistant Tuberculosis：BLMZ Chinese Cohort

NCT07268664 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Rifampicin Resistant Tuberculosis
Pulmonary Tuberculosis
Tuberculosis
Drug-resistant Tuberculosis

Interventions

DRUG: BLMZ

Sponsor

Beijing Chest Hospital

Collaborators

[object Object]
[object Object]